Ability of (18)F-FDG Positron Emission Tomography Radiomics and Machine Learning in Predicting KRAS Mutation Status in Therapy-Naive Lung Adenocarcinoma

SIMPLE SUMMARY: Approximately 26.1% of patients diagnosed with lung adenocarcinoma harbour a KRAS mutation, which is associated with a poorer prognosis. Recent advances in targeted therapy, specifically with sotorasib and MRTX849, have shown promise in targeting KRAS mutations. This retrospective st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruiyun, Shi, Kuangyu, Hohenforst-Schmidt, Wolfgang, Steppert, Claus, Sziklavari, Zsolt, Schmidkonz, Christian, Atzinger, Armin, Hartmann, Arndt, Vieth, Michael, Förster, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377773/
https://www.ncbi.nlm.nih.gov/pubmed/37509345
http://dx.doi.org/10.3390/cancers15143684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377773/
https://www.ncbi.nlm.nih.gov/pubmed/37509345
http://dx.doi.org/10.3390/cancers15143684

Ejemplares similares